Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
EastGroup Properties
EGP
$10.9B
| $5.15M | ﹤0.01% |
43,403
-2,398
| -5% | -$265K |
|
1352
SolarEdge
SEDG
$2.04B
| $5.15M | ﹤0.01% |
37,084
+571
| +2% | +$69.8K |
|
1353
AerSale
ASLE
$275M
| $5.13M | ﹤0.01% |
+500,000
| New | +$5.09M |
|
1354
PUT
Sarepta Therapeutics
SRPT
$1.88B
| $5.13M | ﹤0.01% |
32,000
-106,500
| -77% | -$14.5M |
|
1355
Cousins Properties
CUZ
$4.85B
| $5.13M | ﹤0.01% |
171,810
+19,333
| +13% | +$580K |
|
1356
BHP
BHP
$229B
| $5.12M | ﹤0.01% |
115,401
+21,537
| +23% | +$843K |
|
1357
First Industrial Realty Trust
FR
$8.37B
| $5.12M | ﹤0.01% |
133,118
-65,143
| -33% | -$2.38M |
|
1358
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $5.12M | ﹤0.01% |
129,199
-589,875
| -82% | -$21.8M |
|
1359
Crown Holdings
CCK
$13.2B
| $5.1M | ﹤0.01% |
78,373
+4,543
| +6% | +$286K |
|
1360
Bloomin' Brands
BLMN
$949M
| $5.1M | ﹤0.01% |
478,748
+396,318
| +481% | +$4.1M |
|
1361
CALL
Conagra Brands
CAG
$7.14B
| $5.1M | ﹤0.01% |
145,000
-17,300
| -11% | -$577K |
|
1362
Franklin Electric
FELE
$4.76B
| $5.1M | ﹤0.01% |
97,109
+51,406
| +112% | +$2.55M |
|
1363
Molina Healthcare
MOH
$10.2B
| $5.1M | ﹤0.01% |
28,633
+26,356
| +1,157% | +$4.49M |
|
1364
Coherus Oncology
CHRS
$188M
| $5.09M | ﹤0.01% |
284,913
-124,055
| -30% | -$2.1M |
|
|
IRBT
1365
CALL
DELISTED
iRobot
IRBT
| $5.07M | ﹤0.01% |
60,400
-66,400
| -52% | -$4.37M |
|
1366
Melco Resorts & Entertainment
MLCO
$2.14B
| $5.07M | ﹤0.01% |
326,464
+181,838
| +126% | +$2.81M |
|
1367
CALL
Teva Pharmaceuticals
TEVA
$42.5B
| $5.05M | ﹤0.01% |
410,000
-962,100
| -70% | -$10.9M |
|
|
TCO
1368
DELISTED
Taubman Centers Inc.
TCO
| $5.05M | ﹤0.01% |
133,783
-47,507
| -26% | -$1.94M |
|
1369
Exponent
EXPO
$3.27B
| $5.04M | ﹤0.01% |
62,331
+5,078
| +9% | +$366K |
|
1370
CALL
DexCom
DXCM
$33.6B
| $5.03M | ﹤0.01% |
49,600
+45,600
| +1,140% | +$4.08M |
|
1371
Vanguard Morningstar Total Stock Market ETF
VTI
$690B
| $5.02M | ﹤0.01% |
32,050
+20,806
| +185% | +$3.07M |
|
1372
HF Sinclair
DINO
$15.3B
| $5.01M | ﹤0.01% |
171,532
-78,770
| -31% | -$2.34M |
|
1373
NorthWestern Energy
NWE
$4.38B
| $5M | ﹤0.01% |
91,727
+32,236
| +54% | +$1.87M |
|
1374
Sunstone Hotel Investors
SHO
$1.99B
| $4.99M | ﹤0.01% |
612,471
+63,739
| +12% | +$554K |
|
1375
CALL
Accenture
ACN
$110B
| $4.98M | ﹤0.01% |
23,200
-23,200
| -50% | -$4.39M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.